Utama › Fibrosis Kistik › Kansas › Kansas City
Kajian klinikal Fibrosis Kistik di Kansas City, KS
13 kajian untuk Fibrosis Kistik sedang mencari peserta di lokasi dalam dan sekitar Kansas City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Mengambil pesertaFasa 2
- University of Kansas Medical Center, Kansas City
Sinus Disease in Young Children With Cystic Fibrosis
Mengambil pesertaKajian pemerhatian
- University of Kansas Medical Center, Kansas City
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
Mengambil pesertaKajian pemerhatian
- University of Kansas Medical Center, Kansas City
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Mengambil pesertaFasa 4
- University of Kansas Medical Center, Kansas City
4D-710 in Adult Patients With Cystic Fibrosis
Mengambil pesertaFasa 2
- University of Kansas Medical Center, Kansas City
Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease
Mengambil pesertaKajian pemerhatian
- University of Kansas Medical Center, Kansas City
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- University of Kansas Medical Center, Kansas City
Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
Mengambil pesertaFasa 2
- University of Kansas Medical Center, Kansas City
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
Mengambil pesertaKajian pemerhatian
- University of Kansas Medical Center, Kansas City
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
Mengambil pesertaKajian pemerhatian
- Kansas University Medical Center, Kansas City
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Mengambil pesertaKajian pemerhatian
- University of Kansas Medical Center, Kansas City
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
Mengambil pesertaFasa 2
- University of Kansas Medical Center, Kansas City
A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
Mengambil pesertaFasa 1/2
- University of Kansas Medical Center, Kansas City
Kajian Fibrosis Kistik di bandar lain
- Boston, MA17 kajian
- Birmingham, AL16 kajian
- Philadelphia, PA15 kajian
- Seattle, WA12 kajian
- Baltimore, MD12 kajian
- Denver, CO11 kajian
- Pittsburgh, PA11 kajian
- Dallas, TX11 kajian
- Cincinnati, OH10 kajian
- Los Angeles, CA9 kajian
- Aurora, CO9 kajian
- Minneapolis, MN8 kajian
Kajian lain di Kansas City
- Penyakit Kardiovaskular14 kajian
- Kegagalan Jantung13 kajian
- Obesiti13 kajian
- Penyakit Paru Interstisial13 kajian
- Kanser Payudara12 kajian
- Kanser Pundi Kencing12 kajian
- Leukemia Mieloid Akut12 kajian
- Kanser Prostat12 kajian
- Kanser Paru-paru Bukan Sel Kecil11 kajian
- Kanser Paru-paru11 kajian
- COPD9 kajian
- Asma8 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.